<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/62C544E8-A6D5-4B0C-9773-7A30B21F968D"><gtr:id>62C544E8-A6D5-4B0C-9773-7A30B21F968D</gtr:id><gtr:name>University of Padua</gtr:name><gtr:address><gtr:line1>Universita di Padova</gtr:line1><gtr:line4>Padova</gtr:line4><gtr:postCode>35129</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1AB05DA1-4DD6-4843-B416-D7D9441EBFFB"><gtr:id>1AB05DA1-4DD6-4843-B416-D7D9441EBFFB</gtr:id><gtr:name>Royal Veterinary College</gtr:name><gtr:address><gtr:line1>Royal College Street</gtr:line1><gtr:line2>Camden Town</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW1 0TU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/1AB05DA1-4DD6-4843-B416-D7D9441EBFFB"><gtr:id>1AB05DA1-4DD6-4843-B416-D7D9441EBFFB</gtr:id><gtr:name>Royal Veterinary College</gtr:name><gtr:department>Comparative Biomedical Sciences CBS</gtr:department><gtr:address><gtr:line1>Royal College Street</gtr:line1><gtr:line2>Camden Town</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW1 0TU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1AB05DA1-4DD6-4843-B416-D7D9441EBFFB"><gtr:id>1AB05DA1-4DD6-4843-B416-D7D9441EBFFB</gtr:id><gtr:name>Royal Veterinary College</gtr:name><gtr:address><gtr:line1>Royal College Street</gtr:line1><gtr:line2>Camden Town</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW1 0TU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/62C544E8-A6D5-4B0C-9773-7A30B21F968D"><gtr:id>62C544E8-A6D5-4B0C-9773-7A30B21F968D</gtr:id><gtr:name>University of Padua</gtr:name><gtr:address><gtr:line1>Universita di Padova</gtr:line1><gtr:line4>Padova</gtr:line4><gtr:postCode>35129</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B55E7FBB-A4A2-4EA2-926B-D9856F43B5AD"><gtr:id>B55E7FBB-A4A2-4EA2-926B-D9856F43B5AD</gtr:id><gtr:firstName>Michelangelo</gtr:firstName><gtr:surname>Campanella</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FI013695%2F1"><gtr:id>1A3D34D1-500F-4885-9FD3-408C2DCC573C</gtr:id><gtr:title>Role of the mitochondrial Translocator Protein (mTSPO) in cell homeostasis: a molecular pathway in signalling and self-conservation mechanisms</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/I013695/1</gtr:grantReference><gtr:abstractText>In search of the molecules that may set the pace of cell metabolism and define its healthy homeostasis, we are now interested in elucidating the cell biological role of the mTSPO. Although associated with many pathophysiological conditions, its contribution to processes guarding cell integrity such as autophagy and apoptosis is obscure, and its role in mitochondrial performance ill-defined. In order to shed light on these two fundamental processes, it will be instructive to ascertain how mTSPO ratio of expression with that of the VDAC, and its pharmacological modulation, defines the signalling of Ca2+, dynamics of the ROS, ATP rationing and Redox State. The physiology of cellular Ca2+, the ATP balance, the programmed apoptotic cell death as well as the Autophagy all depend on the efficient handling of Ca2+ by the mitochondrion. Despite some minor attempts, however, the contribution of mTSPO to this pathway of signalling has been largely ignored, and we now aim to explore and elucidate it, considering this as the hub in the mTSPO contribution to mitochondrial coupling by which ATP synthesis, ROS generation and network remodelling, via targeted autophagy, originate. However, modifications in ROS signalling would impinge also on downstream effectors: the kinases which promote the unphysiological phosphorylation of VDAC. This indirect pathway, as well as the direct physical interaction between mTSPO and VDAC, will therefore be addressed as potential underlying mechanisms. The following experiments will clarify the above points using Mouse Embryonic Fibroblasts (MEF) cell lines: 1. Live imaging, luminescent and fluorescence based methods will be used to assess mTSPO role in cell autopagy and signalling. a) The mTSPO protein will be transiently manipulated to increase (+) or decrease (-) its expression via conventional techniques of molecular biology; the outcome of this manipulation will then be ascertained on b) Autophagy, c) Ca2+ signalling d) ROS generation and e) Autophagy in conditions of buffered Ca2+ and ROS. 2. Confocal Microscopy, fluorescence and biochemical based methods will be used to determine the role of mTSPO in mitochondrial coupling efficiency and remodelling. After transient modulation of mTSPO or pharmacological binding the following will be addressed: a) The mitochondrial redox state, b) ATP generation, and c) Mitochondrial membrane potential, will be evaluated; d) The volume of the mitochondrial network will be calculated; e) The expression of genes associated with the organelle's genesis will be profiled, and f) The activity of mitochondria-triggered autophagy will be investigated. 3. Live cell imaging and standard assays will test the kinases' activity, VDAC phosphorylation which this generates, and the outcome in mitochondrial regulated apoptotic demise. Following molecular and pharmacological modulation of mTSPO: a) The efficiency of translocation and activity of PKA and PKCepsilon will be evaluated; b) The phosphorylation state of VDAC revealed; and c) The efficiency of mitochondrial-dependent apoptosis assessed. This object will also see the utilization of MEF cell lines from PKCepsilon KO mice. 4. Immunohistochemical, biochemical and yeast based methods will be employed to identify the molecular interplay between mTSPO and VDAC: a) Cellular co-localization between mTSPO and VDAC isoforms will be monitored; b) The interaction and its type studied via two-hybrid strategy and co-immunoprecipitation; and c) The homo-oligomers of VDAC evaluated. All this will reveal the molecular and cellular physiology of an important but so far neglected regulatory pathway. The results of our studies will form a conceptual and experimental framework for future investigations aiming to identify in mTSPO a novel bio-marker and target for pharmacological intervention of conditions associated with remodelling of metabolism and proliferation.</gtr:abstractText><gtr:technicalSummary>By manipulating mTSPO expression or pharmacologically inhibiting its function in Murine Fibroblasts we aim to assess: 1) Cell autophagy and signalling; 2) Mitochondrial homeostasis and remodelling; 3) Kinase-mediated phosphorylation of VDAC and the result on apoptosis, and 4) Nature of mTSPO and VDAC interaction. Seventeen experiments were designed which break down as follows: I. 1. By techniques of molecular biology modify mTSPO up and down regulating its expression with recombinant protein and short hairpin RNA; 2. By combining means of imaging and biochemistry define the outcome of this on cell autophagy; 3. Evaluate the homeostasis of Ca2+ with fluorescence and luminescence tools. Monitor 4. The intracellular level of ROS; 5. Autophagic activity after Ca2+ and ROS neutralization. II. 6. Mitochondrial pools of NAD will be evaluated via confocal analysis. 7. Both cell imaging and luminescent techniques will be used to assess ATP generation. 8. Inner mitochondrial membrane potential will be imaged and 9. Via combined fluorescent probes and dyes the volume fraction of the organelles pondered. 10. The genes responsible for the biogenesis of the mitochondria expansion will be mapped with RT-QPCR and Immunoblotting as well as 11. Targeted autophagosomes investigated. III. 12. Test PKA and PKCepsilon activity and mitochondrial localization following activation in cells manipulated for mTSPO expression in response to PK11195 treatment; in the same cells 13. Analyze by immunoblotting VDAC phosphorylation and 14. Exploit the results of this conformational change on the intrinsic pathway of apoptosis. IV. 15. The co-localization of mTSPO and VDAC will be scrutinized by immunofluorescence and immunoblotting. 16. The interaction between the two proteins profiled by conventional immunoprecipitation and yeast two-hybrid system. Lastly, 17. Clarify via biochemical analysis if VDAC homo-oligomers are affected by mTSPO modified expression or pharmacological modulation.</gtr:technicalSummary><gtr:potentialImpactText>The cell biology of the mTSPO remains enigmatic and unexplored although the literature provides evidence for its involvement in cholesterol transport, synthesis of steroid hormones, apoptosis, cell proliferation and immunomodulation. Binding of the mTSPO with [11C](R)-PK11195 via positron emission tomography (PET) is routinely employed to diagnose inflammatory states of the Central Nervous System (CNS) as mTSPO level of expression is increased in activated microglia. mTSPO ligands are also used in experimental protocols to mark cancerous cells where mTSPO is remarkably over-expressed. In spite of that, the actual contribution of mTSPO in regulation of metabolism and mechanisms to avoid cellular pathologies remains unexplained. This proposal aims to address these fundamental aspects of cell physiology associated with mTSPO and to inform novel approaches in which mTSPO can be considered in the context of the diagnosis and treatment of pathologies. We have therefore identified the following principal points of impact for this study: I. The growing interest by pharmaceutical and biotechnological companies in the outcomes of our study will be further exploited, and strategies to foster collaborative work established. The first aim is to create a bond with partners for the creation of protocols for clinical purposes in order to consolidate mTSPO as read-out of pathological conditions, as well as functional assays to assess the efficacy of therapeutic agents acting on it. Nevertheless, we are currently working to identify the ideal partner to present a case for a PhD studentship to increase the number of people involved in the subject. II. The data generated will be pubblished by various activities set ad hoc for the project. The relevance of this fundamental research to major diseases means it has general and popular interest, contributing to greater public awareness and understanding of science. III. A thorough understanding of the protein's cell biology will assist specialists developing therapies directed to this protein. The eventual patenting of the intellectual property that may arise from this project will be provided by the appointed organisation of the college. This will be made possible by the close involvement of the Enterprise Team of the Royal Veterinary College, from the earliest stages in research project development, which will provide assistance in impact planning, identification of and liaison with company partners as well as in formalizing commercial contracts. Pro-active market research and marketing are used to identify and develop relationships with potential licensee businesses. Proof-of-concept funding will be accessed, whenever appropriate and available, for market research and technical development to enhance the appeal of new developments for commercial partners. IV. The major findings from this project will be disseminated accordingly and people involved in the research will contribute to that by providing interviews or press quotes as appropriate. To this end, we will also benefit from the Communications Management Team who will advise on the creation of web-based material for publicising the work to a general audience. V. Staff appointed to run this project will benefit from highly qualified training, becoming skilled in cutting-edge techniques for cell-based investigation. In conclusion, the results of this work will lead to a greater understanding of molecular regulators of cell energy and quality. A deeper comprhension of the mTSPO role will enable novel approaches to diagnose and manage diseases related to alterations of pathways associated to malfunctions of autophagy, metabolism and apoptosis. Hence the economy (e.g. Pharmaceutical and Biotechnological companies) may benefit from this study as well as the quality of life of cohorts of patients by the development of novel therapeutics.</gtr:potentialImpactText><gtr:fund><gtr:end>2014-11-06</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2011-11-07</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>414361</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy</gtr:department><gtr:description>Cell Biology and Pharmacology Elucidation of Mitophagy Activators</gtr:description><gtr:id>F49A1445-21E4-4CE0-9467-DE2B3B942020</gtr:id><gtr:impact>One Manuscript published</gtr:impact><gtr:outcomeId>5460bdf3479118.93076549-1</gtr:outcomeId><gtr:partnerContribution>Our work proved instrumental to move forward the development of chemicals synthesised by Geoff Wells and collaborators as well as to consent an actual technological improvement in the field of mitophagy activation/regulation.</gtr:partnerContribution><gtr:piContribution>My team assessed the in cell function of chemicals devised by colleague of the UCL SoP (Dr. Geoff Wells).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Brain Bank</gtr:department><gtr:description>Elucidate the Neuronal Cell Biology of the Neuroimaging Tool TSPO</gtr:description><gtr:id>3033B66A-338E-48CE-8E92-776E2F5EC591</gtr:id><gtr:impact>A manuscript is now submitted for final revision which will outline TSPO role in neurotoxicity besides characterising its function in cell signalling homeostasis.</gtr:impact><gtr:outcomeId>545bc6bb5cd7d2.86354672-1</gtr:outcomeId><gtr:partnerContribution>Research Grant Share to support a PDRA and consumable.</gtr:partnerContribution><gtr:piContribution>Coordination of the research work on functional role of the PET tracer TSPO in neuronal cell physiology and toxicity determination.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Veterinary College (RVC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Comparative Biomedical Sciences</gtr:department><gtr:description>TSPO role in Osteoarthritis (OA) and Bone Remodelling</gtr:description><gtr:id>752C979C-39EB-4635-BF30-3736A3ACD9E3</gtr:id><gtr:impact>We have a drafted manuscript to be soon submitted</gtr:impact><gtr:outcomeId>56e14a572e6264.91840122-1</gtr:outcomeId><gtr:partnerContribution>Our contribution consisted in defining the pattern of expression and role in mitochondrial morphology and quality control mediation.</gtr:partnerContribution><gtr:piContribution>We are dissecting the contribution by TSPO in Osteoarthritis (OA) and mediated bone pathology. We are doing so in respect of the role played by TSPO in general and targeted autophagy (mitophagy).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>TSPO role in Hormonal Chemotherapy Resistance</gtr:description><gtr:id>F1DE5422-37A1-4652-9284-430B34A5B340</gtr:id><gtr:impact>Grants is being drafted</gtr:impact><gtr:outcomeId>56e14e837c74e7.94134370-1</gtr:outcomeId><gtr:partnerContribution>The main goal is trap the definition of pro-survival genes transcription mediated by TSPO and its potential intracellular relocation from mitochondrial outer membrane when pathologically overexpressed. 

Concomitantly TSPO ligands are being tested as pharmacological means to facilitate/promote chemotherapy induced cell death and prevent long-term resistance.</gtr:partnerContribution><gtr:piContribution>We are defining the link between cholesterol mediated resistance to hormonal chemotherapy and TSPO triggered expression in mammary cancer models.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Padova</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>TSPO role in Cancer Cell Biology and Oncogenesis</gtr:description><gtr:id>CE861F15-7523-4CD9-9BC0-35017B34133A</gtr:id><gtr:impact>There are two manuscripts finalised to be submitted in the incoming months and another grant application under evaluation.</gtr:impact><gtr:outcomeId>56dd6f2417f3b8.84482800-2</gtr:outcomeId><gtr:partnerContribution>We designed, developed and completed the experimental work and immunohistochemial analysis on TSPO on breast cancer tissues.
An accurate evaluation of the underlying regulatory pathways is currently progressing which should lead to an high impact revaluation of the mitochondria-nucleus signalling.</gtr:partnerContribution><gtr:piContribution>We received extra charity funds to run parallel work on the comparative relevance of TSPO role in cancer biology and oncogenesis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Veterinary College (RVC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>TSPO role in Cancer Cell Biology and Oncogenesis</gtr:description><gtr:id>9E34D246-A5EB-4D5C-8DE5-10F83E80E8E6</gtr:id><gtr:impact>There are two manuscripts finalised to be submitted in the incoming months and another grant application under evaluation.</gtr:impact><gtr:outcomeId>56dd6f2417f3b8.84482800-1</gtr:outcomeId><gtr:partnerContribution>We designed, developed and completed the experimental work and immunohistochemial analysis on TSPO on breast cancer tissues.
An accurate evaluation of the underlying regulatory pathways is currently progressing which should lead to an high impact revaluation of the mitochondria-nucleus signalling.</gtr:partnerContribution><gtr:piContribution>We received extra charity funds to run parallel work on the comparative relevance of TSPO role in cancer biology and oncogenesis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biosciences</gtr:department><gtr:description>TSPO role in Cancer Cell Biology and Oncogenesis</gtr:description><gtr:id>B4EB8E97-E04D-4904-9287-4E8AFC683DFE</gtr:id><gtr:impact>There are two manuscripts finalised to be submitted in the incoming months and another grant application under evaluation.</gtr:impact><gtr:outcomeId>56dd6f2417f3b8.84482800-3</gtr:outcomeId><gtr:partnerContribution>We designed, developed and completed the experimental work and immunohistochemial analysis on TSPO on breast cancer tissues.
An accurate evaluation of the underlying regulatory pathways is currently progressing which should lead to an high impact revaluation of the mitochondria-nucleus signalling.</gtr:partnerContribution><gtr:piContribution>We received extra charity funds to run parallel work on the comparative relevance of TSPO role in cancer biology and oncogenesis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Keystone Symposia-Autophagy</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>680CA89C-85A7-4275-98BF-DF059445A21C</gtr:id><gtr:impact>Decisive moment to broadcast our science on the regulation of mitochondrial autophagy by TSPO and convince on the solidity of the model.

Impact was quite immediate as right after the presentation of the work orally to a competent audience our manuscript at the moment pending was finally accepted by the journal of Autophagy (11.35IF).</gtr:impact><gtr:outcomeId>545fe31b877669.10730529</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keystone Symposia: Mitochondrial Dynamics and Physiology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2E56E750-F7BA-45D2-B49C-E1C9AD0D49D1</gtr:id><gtr:impact>Poster presentation stimulated many questions and fruitful discussion during and after the poster session.

Constructive discussion of the work assisted in the finalisation and publication of a research manuscript. Greater awareness of the research also promoted increased collaborative interest.</gtr:impact><gtr:outcomeId>5460abec90b944.40208259</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MitOX</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0B3E0464-EE8C-462C-B1D6-A144218B9148</gtr:id><gtr:impact>Invited Plenary Talk on TSPO</gtr:impact><gtr:outcomeId>56e17959c8a8c6.93685036</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> EMBO workshop on Autophagy</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4AA4DF21-7755-43E7-AFFB-37E07004754F</gtr:id><gtr:impact>Plenary selected talk to share our latest on the topic begun and currently developed with BBSRC support</gtr:impact><gtr:outcomeId>56e1501d485e56.37404195</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Rotary International Seminars</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FB680F10-0228-468E-911E-F63F38807DD6</gtr:id><gtr:impact>Attention by general public on the activities within research laboratories and practice of research was raised.

Continuos request for updates on science progress and activities run in the laboratory of research I am leading.</gtr:impact><gtr:outcomeId>5457b1ee3f3150.97378378</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>59th Biophysical Society Meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FF52072E-ECB9-4F53-8325-698468E5B793</gtr:id><gtr:impact>Invited Talk within ad hoc symposium on TSPO</gtr:impact><gtr:outcomeId>56e15075659fd0.11708594</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>World Congress of Pharmacology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A5C4790E-C22A-4A29-B3EA-D9B270F9D8B9</gtr:id><gtr:impact>The latest results presented at the congress sparked genuine interest in the community of colleagues working in the field of cell sigalling and pharmacology.

Given the appreciation and interest for our work colleagues active at the far front of signal transduction and tools devising to monitor key cellular parameters offered collaboration and their latest probes to continue in our endeavors with their support at the far front of the field.</gtr:impact><gtr:outcomeId>545fec28980234.50752083</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biochemical Society-BBSRC Sparking Impact Focused Meeting on TSPO</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>03E07F21-5577-4635-A767-9A2C0C37BD32</gtr:id><gtr:impact>Two days focused meeting</gtr:impact><gtr:outcomeId>56e150cb014022.38260206</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>60th Biophysical Society Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>77ED7C1B-C77B-4209-915A-470CF6234359</gtr:id><gtr:impact>Data presentation on the past, current and future TSPO related activities of the laboratory of research lead by MC</gtr:impact><gtr:outcomeId>56e1516348d9f2.49922732</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mitochondria, metabolic regulation and the Biology of Aging 13th - 16th February 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>59A992EA-EBC7-4C6A-87C7-1492B866AC03</gtr:id><gtr:impact>The talk sparked major interest on the line of research in the community of experts active in the field of mitochondrial role in cell physiology and pathology.

The topic of research core of my talk TSPO begun to receive essential attention by colleagues.</gtr:impact><gtr:outcomeId>545fdc15105a13.74322154</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Neuroinflammation  workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E3DE4FA0-F7D2-4D2F-9C38-698FB1FC79E9</gtr:id><gtr:impact>Invited Plenary Talk in focused event on TSPO use in diagnostic and possibly treatment of neuroinflamation.</gtr:impact><gtr:outcomeId>56e1539036ed05.20535268</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Anglo-Israeli Workshop 18-21 February 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>07905FA6-C160-4DA9-B893-E07F01D7D8E7</gtr:id><gtr:impact>Key activity to build up collaborations and consequent exchange of reagents with experts based abroad.

Merging forces and hence maximize the impact on mitochondrial science via the novel level of understanding of TSPO functional biology.</gtr:impact><gtr:outcomeId>545fde08bf01e4.18340291</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Cell Death Organization Annual Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>746590BC-DD73-4E06-A65B-1FEE0CECD05F</gtr:id><gtr:impact>The work on TSPO role in apoptotic cell death regulation grasped the interest of many senior and affirmed colleagues which awarded the work of a fellowship covering the expenses of meeting participation by the poster's presenter (my PhD Student).

The presentation of the paper made me known at the ECDO executives and leading figures in the organization with whom I started to collaborate and consequently published in the subsequent years.</gtr:impact><gtr:outcomeId>545fedffc50591.00390123</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Morrison Animal Foundation</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Morris Animal Foundation</gtr:fundingOrg><gtr:id>981B375A-18DC-41B6-8883-D97325FFB467</gtr:id><gtr:outcomeId>545bbcd53a7d21.91865062</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/N007042/1</gtr:fundingRef><gtr:id>1EE106EC-41D6-4227-A41D-649015208CFF</gtr:id><gtr:outcomeId>56ded5e22ec349.86821755</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Bloomsbury Colleges</gtr:fundingOrg><gtr:fundingRef>Imaging the Ageing Brain: Cellular and PET Tracing of  the Neuroinflammatory Protein TSPO</gtr:fundingRef><gtr:id>EAB8902A-1C26-4457-AFE6-8CFF944AAF96</gtr:id><gtr:outcomeId>56ded4566bdc38.74554965</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC iCase Studentship</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>Bioactive targets of mitochondrial quality control and function.</gtr:fundingRef><gtr:id>47922144-CBA3-4848-A67E-F24382B1CE2F</gtr:id><gtr:outcomeId>56ded5437da970.73328209</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Internal-PhD Studentship</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Royal Veterinary College (RVC)</gtr:fundingOrg><gtr:id>703C08F5-5552-40AD-A12C-45A8DF309AF1</gtr:id><gtr:outcomeId>545ac216688fc0.15011134</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC-iCase Studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>Focusing on the mitochondrial expression of TSPO as a marker and promoter of neuroinflammation</gtr:fundingRef><gtr:id>AC271C30-FF63-40C2-A1F6-8D9B797C8233</gtr:id><gtr:outcomeId>56ded4e94f9e03.73888561</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PPCT-Full Research Grant</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Petplan Charity</gtr:fundingOrg><gtr:id>56551CE3-3754-473F-A930-F5AC755F2E1C</gtr:id><gtr:outcomeId>545ac0658efa66.37612328</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>105000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC-LiDo Studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>Imaging the Ageing Brain: Cellular and PET Tracing of the Neuroinflammatory Protein TSPO</gtr:fundingRef><gtr:id>DF3FEC41-B83E-46ED-BAC7-8279A2CC3111</gtr:id><gtr:outcomeId>545bb9d5b75027.93682858</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Keystone Symposia Future of Science Fund</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Keystone Symposia on Molecular and Cellular Biology</gtr:fundingOrg><gtr:id>7921CB7F-3A7F-4F3C-A594-8436314572E6</gtr:id><gtr:outcomeId>5460b507a4d5b7.38141731</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Bloomsbury Colleges-PhD Studentship</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Bloomsbury Colleges</gtr:fundingOrg><gtr:id>E02E8E35-0082-4C07-9A66-2B1A2590591F</gtr:id><gtr:outcomeId>545ac281b30b35.67923079</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The research-work made possible via the support of the BBSRC BB/I013695/1 grant has taken to a new level of general understanding of the functional role played by TSPO in mitochondrial cell homeostasis. 
Till the assignment of this award, TSPO has prelvantly gained attention by clinically orientated segments of science, and its core cell biology has remained ill-defined thus limiting the full comprehension of its actual contribution to cell physiology and its exploitation for diagnosis and treatment of cell and tissues conditions.

Having discovered hidden aspects of TSPO physiology such as its contribution to quality control of mitochondria (mitophagy) and cell apoptosis - both core regulatory processes of cellular wellbeing- we have obtained attention by colleagues (both at national and international level) active in these fields of science which stemmed in collaborations and greater interest for TSPO.
Equal degree of interest was also granted by colleagues exploiting TSPO in clinical scenarios with whom we are now constantly collaborating towards a more immediate and tangible impact on healthcare diagnostic and treatment. 
This award proved therefore instrumental to permit the stabilization of my group of research via an expertise renown around the globe focused on TSPO and pathways for the determination of mitochondrial function.

Our findings on fundamentally relevant aspects of TSPO biology are now permitting the outline of an experimental model in which decay of mitochondrial autophagy can be scored by the accumulation of this protein. In parallel, being the expression level of TSPO increased during ageing (a very recent discovery) we are now in the position to focus to corroborate a framework in which TSPO represents a molecular read-out for mitochondrial function deregulation which underlies ageing. 
The notions obtained and shared till this point have been used both by academic colleagues and industry to input their protocols and particularly fine-tune TSPO-focused products which will eventually impact health-care via improved diagnostic and targeting approaches. 

Work published (see publications returned), together with talks and presentations in international meetings and symposia have had the merit to pave the way to future prospective for TSPO science as well as places UK at the far front of TSPO experimental biology. 

The BBSRC sparking impact meeting -chaired by us- and to be held in December 2014 at the Royal Veterinary College will represent the pinnacle of this common endeavour, as it will summon expertise from different fields of basic and clinical science aligning a common strategy to impact at various levels via the improved TSPO knowledge.</gtr:description><gtr:firstYearOfImpact>2013</gtr:firstYearOfImpact><gtr:id>B96A1DF2-A3EE-4732-A9BC-C53A4AA98ED9</gtr:id><gtr:impactTypes><gtr:impactType>Cultural</gtr:impactType></gtr:impactTypes><gtr:outcomeId>5457b2c5b40a01.18598493</gtr:outcomeId><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology,Other</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Characterisation of a sentinel molecule to mitochondrial toxins.</gtr:description><gtr:grantRef>BB/I013695/1</gtr:grantRef><gtr:id>887B112E-C3C0-447E-928E-1BA547983232</gtr:id><gtr:impact>The long-term impact will be on drugs attritions since many of these fail for associated mitochondrial toxicity.The impact envisaged shall therefore be at industrial level in the drugs discovery sector.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c7e3e951fe87.29404159</gtr:outcomeId><gtr:patentId>RVCBY/P58617GB</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Invention in the field of mitochondrial function and structure</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>Mitochondria play a vital role in the wellbeing of mammals. Quality of their function and hence their ability to master signaling events occurring in their hosting environment (the cell) are at the basis of any biological function which impacts at systemic level.
With the completion of this program of research we have demonstrated that TSPO expression ration in mitochondria contributes the quality of vital intracellular signals such as Ca2+, the Reactive Oxygen Species (ROS) and that of the whole pace of mitochondrial bio-energy. In addition TSPO accumulation alters the morphological aspects of the mitochondria.
The scientific evidences collected during the grant have demonstrated that TSPO can really be seen as a molecular regulator of the mitochondrial channel (VDAC) via which metabolites pass from the cytosol into the organelle: a vital step of the organelle's regulation. We have indeed been able to demonstrate in the physical interaction between TSPO and VDAC the drive of the outcome on mitochondrial and cellular physiology.
TSPO, when accumulated in the mitochondria, prevents the execution of organelle-mediated apoptosis thus underlying a pathological cellular proliferation sustained by the oxidative stress caused by the parallel inhibition of mitophagy.


In detail we have been able to demonstrated that TSPO:
1- Plays part in cell autophagy regulating the mitochondrial type of it.
2- Affects mitochondrial metabolism and structure reducing the efficient coupling of the organelle as well as the network dynamics.
3- Prevents mitochondrial apoptosis causing the phosphorylation of VDAC via the activation of the cellular Kinases.
4- Directly and indirectly affects the degree of VDAC phosphorylation regulating its molecular physiology.

We are therefore confident that our work has brought to light a regulatory molecular pathway which, by defining cell metabolism as well as the fundamental mechanisms of cell integrity preservation, impacts the wellbeing of tissues and mammals outlying strategies of intervention.</gtr:description><gtr:exploitationPathways>Based on the work produced and results obtained we are highlighting below the specific aspects in which we can predict further development in the years to come 

(1) Mitochondrial Quality control and Ageing. The biological evidences obtained with the support of this grant have lead towards the exploitation of TSPO as a potential time-reader of mitochondrial ageing thus making the molecule a valuable target for cutting-edge diagnostic of cell and tissues senescence. This is part of the work we are keen to progress with colleagues based at Imanova, King's College London and Imperial College active in the clinical diagnostic.

(2) Cell Metabolism and Deterioration. The knowledge we have obtained with this grant will be of assistance to perfect the tracers currently used in Positron Emission Tomography studies an din this way improve the quality of their reading. Specifically, the accumulation of cellular free species of the oxygen (ROS), which we found depending on TSPO accumulation, may be the cause of the unclear signal recorded in occasions and therefore stimulate the investigation of protocols to combine anti-oxidant treatment to standards means of PET tracers infusion.

(3) Apoptosis Regulation. The efficacy of chemotherapy could be improved by combining the treatment with standard anti-cancer drugs with that of compounds active on TSPO. The pharmacological &amp;quot;masking&amp;quot; of TSPO could indeed represent a means to improve the efficacy of cancer treatment. Pilot studies are now running to maximise the fundamental discoveries matured from this grant.

(4) Methodological Improvements. The degree of the mitochondrial accumulation of TSPO could per se represent a methodological advancement to score mitochondria that have evaded the process of cell mitophagy. However, the characterization of the pro-mitophagic tool PMI will become vastly utilized by colleagues engaged in the understanding of mitophagy and its exploitation for therapeutic purposes. This is another great merit of this research-grant.</gtr:exploitationPathways><gtr:id>DEE0492B-9D33-414F-8766-6A74DC04D65B</gtr:id><gtr:outcomeId>545bce3b0ed5d4.09627352</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology,Other</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We are devising a way via which we can score tumor stages in animals by checking TSPO expression</gtr:description><gtr:id>935BD9D8-447A-4ADC-BD08-B3F39A6E357D</gtr:id><gtr:impact>A potential way to image diagnostically tumor stage and progression via TSPO</gtr:impact><gtr:outcomeId>56e15404639555.10911951</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cancer Biomarker</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A new tool to physiologically activate mitophagy which we called PMI as working via the p62 pathway.</gtr:description><gtr:id>4EF145EA-F77A-4411-91A6-BE258FEAA5E3</gtr:id><gtr:impact>Mitochondrial quality control is a fundamental process in cellular homeostasis, and its deficiency is linked to several
neurodegenerative diseases and cancers. Despite this, the discrete mechanisms, regulatory pathways, and impact oncellular physiology are still far from being elucidated. The current canonical methods to trigger mitophagy in vitro typically involve the abrupt depolarization of mitochondrial membrane potential (DYm) using ionophores such as carbonyl cyanide m-chlorophenyl hydraz</gtr:impact><gtr:outcomeId>5457ad55a61b98.44512302</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mitophagy Inducer</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>47BF0907-CF46-4435-82A5-44D8ED0C78C8</gtr:id><gtr:title>Ca2+ in quality control: an unresolved riddle critical to autophagy and mitophagy.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32ae22c3b6f9cd25f97fdc84ab9b3d18"><gtr:id>32ae22c3b6f9cd25f97fdc84ab9b3d18</gtr:id><gtr:otherNames>East DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>545bae18dd0920.09328941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4874DB6-3BD7-404F-944F-3E51382FC1AF</gtr:id><gtr:title>Control of Mitochondrial Remodeling by the ATPase Inhibitory Factor 1&amp;nbsp;Unveils a Pro-survival Relay via OPA1.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/432a93a0abc1c455d7acbe3bdeeae1de"><gtr:id>432a93a0abc1c455d7acbe3bdeeae1de</gtr:id><gtr:otherNames>Faccenda D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c7d2924093d3.61639629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39786405-BF63-4CFF-BF78-047E1ACB28D8</gtr:id><gtr:title>A role for TSPO in mitochondrial Cahomeostasis and redox stress signaling.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94366f16d8e04e920c02db3b18cf29e7"><gtr:id>94366f16d8e04e920c02db3b18cf29e7</gtr:id><gtr:otherNames>Gatliff J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aa7ae8a813358.31142736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA94F9F5-CEF8-428B-8ED0-35E36A2CC8BA</gtr:id><gtr:title>TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94366f16d8e04e920c02db3b18cf29e7"><gtr:id>94366f16d8e04e920c02db3b18cf29e7</gtr:id><gtr:otherNames>Gatliff J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>5457a9f73ec202.27319163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>458B8998-5DFC-4C6E-BB14-382CAF8C1F46</gtr:id><gtr:title>Molecular Regulation of the Mitochondrial F(1)F(o)-ATPsynthase: Physiological and Pathological Significance of the Inhibitory Factor 1 (IF(1)).</gtr:title><gtr:parentPublicationTitle>International journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/432a93a0abc1c455d7acbe3bdeeae1de"><gtr:id>432a93a0abc1c455d7acbe3bdeeae1de</gtr:id><gtr:otherNames>Faccenda D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1687-8876</gtr:issn><gtr:outcomeId>5a2fcbd4b58a93.07570564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D6D3C5C-747C-45D5-9654-58FE7E12FF39</gtr:id><gtr:title>Neuroprotective coordination of cell mitophagy by the ATPase Inhibitory Factor 1.</gtr:title><gtr:parentPublicationTitle>Pharmacological research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c967aeac745ed9d23adaeac49e92894"><gtr:id>0c967aeac745ed9d23adaeac49e92894</gtr:id><gtr:otherNames>Matic I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1043-6618</gtr:issn><gtr:outcomeId>56ded3b87d82a3.43057992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D87CD702-1512-47E5-BF19-CD5ABBAF1B73</gtr:id><gtr:title>Culturing muscle fibres in hanging drop: a novel approach to solve an old problem.</gtr:title><gtr:parentPublicationTitle>Biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61b620105b75c091ea017daf8670795b"><gtr:id>61b620105b75c091ea017daf8670795b</gtr:id><gtr:otherNames>Archacka K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0248-4900</gtr:issn><gtr:outcomeId>56e17676f421e4.43895996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CCE5283-4FED-4F35-854B-79FDF5C5089B</gtr:id><gtr:title>Controlled and Impaired Mitochondrial Quality in Neurons: Molecular Physiology and Prospective Pharmacology.</gtr:title><gtr:parentPublicationTitle>Pharmacological research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c967aeac745ed9d23adaeac49e92894"><gtr:id>0c967aeac745ed9d23adaeac49e92894</gtr:id><gtr:otherNames>Matic I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1043-6618</gtr:issn><gtr:outcomeId>56ded3b83a12a4.28702994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CAB4194-C64D-40A3-8F85-8A00721A0649</gtr:id><gtr:title>Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d6d1d31091220abdfa0de734ca651ea"><gtr:id>3d6d1d31091220abdfa0de734ca651ea</gtr:id><gtr:otherNames>Shah DI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56e17765bf5467.64501315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95AD52BB-DF23-4320-9FC8-5D7E32A2AD43</gtr:id><gtr:title>AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12c01cd994772e06b58e76a33ac22d5e"><gtr:id>12c01cd994772e06b58e76a33ac22d5e</gtr:id><gtr:otherNames>Strappazzon F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>5457a795c68c96.84461786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62967887-3CA3-4C2E-9594-FC052B5AE938</gtr:id><gtr:title>Mitochondrial IF&amp;acirc;?? preserves cristae structure to limit apoptotic cell death signaling.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/432a93a0abc1c455d7acbe3bdeeae1de"><gtr:id>432a93a0abc1c455d7acbe3bdeeae1de</gtr:id><gtr:otherNames>Faccenda D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>56e1752b0f18b2.84280631</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92162ED9-3DFD-4654-8FF3-3CD634F77761</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>56ded3b8a47574.95872754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB21FB90-0205-4E0A-8BC5-98F096014ECC</gtr:id><gtr:title>Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e476d3674e292a046edc7669c4a8396f"><gtr:id>e476d3674e292a046edc7669c4a8396f</gtr:id><gtr:otherNames>Beffagna G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c7d292dd5fc1.88113620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED46FBAD-2D4D-4A87-9928-99AE373CF43E</gtr:id><gtr:title>Mitophagy and the therapeutic clearance of damaged mitochondria for neuroprotection.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32ae22c3b6f9cd25f97fdc84ab9b3d18"><gtr:id>32ae22c3b6f9cd25f97fdc84ab9b3d18</gtr:id><gtr:otherNames>East DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>58c7d29312bcf4.08712478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F41200C5-DC50-43DB-8699-724A50DA4FFA</gtr:id><gtr:title>The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e451af62459dba4a9f16280ca61787f"><gtr:id>8e451af62459dba4a9f16280ca61787f</gtr:id><gtr:otherNames>Galavotti S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>5457a80d431021.91976005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6EF242B-4D24-40F4-9A4B-92539AF37AD8</gtr:id><gtr:title>Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/985daa6c682db24b1c2b0b9d0de8b00b"><gtr:id>985daa6c682db24b1c2b0b9d0de8b00b</gtr:id><gtr:otherNames>Hawkins KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>58c7d292aee500.95549651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1322C742-39A3-4ACF-995E-9E6F4821F6A0</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>56e174f0097f54.76115306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>062B3FA1-2AC9-431B-B0B6-BF7330BDD496</gtr:id><gtr:title>The compound BTB06584 is an IF1 -dependent selective inhibitor of the mitochondrial F1 Fo-ATPase.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01e61f06daff385c3ca0667886a18ea7"><gtr:id>01e61f06daff385c3ca0667886a18ea7</gtr:id><gtr:otherNames>Ivanes F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>doi_55f94d94d6e1a6d9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>863ED060-0920-45D7-A544-E8B5DA6B8A8E</gtr:id><gtr:title>PMI: a &amp;Icirc;?&amp;Icirc;&amp;uml;m independent pharmacological regulator of mitophagy.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32ae22c3b6f9cd25f97fdc84ab9b3d18"><gtr:id>32ae22c3b6f9cd25f97fdc84ab9b3d18</gtr:id><gtr:otherNames>East DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>5457a98b4266a7.40431028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F557349-1F22-40B7-90AB-77FA9C5FA162</gtr:id><gtr:title>Regulation of mitochondrial morphogenesis by annexin A6.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59fabd98617d4d976a32769910c88583"><gtr:id>59fabd98617d4d976a32769910c88583</gtr:id><gtr:otherNames>Chlystun M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e176e855d687.83150866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>189AB5D2-F0CD-40B1-940B-60DEE7AD01A2</gtr:id><gtr:title>Mitochondrial pharmacology: A need in modern biomedicine.</gtr:title><gtr:parentPublicationTitle>Pharmacological research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7c63f89cbea82fb1d59d999de7a678"><gtr:id>9f7c63f89cbea82fb1d59d999de7a678</gtr:id><gtr:otherNames>Campanella M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1043-6618</gtr:issn><gtr:outcomeId>56e1758f11d0e6.60530340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B20AD41C-556A-4A8C-A9DC-6C59C381AA41</gtr:id><gtr:title>Keeping the engine clean: a mitophagy task for cellular physiology.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7c63f89cbea82fb1d59d999de7a678"><gtr:id>9f7c63f89cbea82fb1d59d999de7a678</gtr:id><gtr:otherNames>Campanella M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>545bc44f502439.95790126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE9B49F5-1191-4811-9C1E-34E3B5F44917</gtr:id><gtr:title>The shrimp mitochondrial FoF1-ATPase inhibitory factor 1 (IF1).</gtr:title><gtr:parentPublicationTitle>Journal of bioenergetics and biomembranes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7c67021d5529a1bec0370c2ead5a05f"><gtr:id>a7c67021d5529a1bec0370c2ead5a05f</gtr:id><gtr:otherNames>Chimeo C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0145-479X</gtr:issn><gtr:outcomeId>56ded3b858f196.24569405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27468C78-D7E1-4FFD-83D1-CAA42F3E53E9</gtr:id><gtr:title>The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f8d4aa27633724cf58a08adab406a51"><gtr:id>7f8d4aa27633724cf58a08adab406a51</gtr:id><gtr:otherNames>Vara D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>56e177b199bdf5.49807977</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B7C8017-7AF3-432B-94F3-2B3947286B03</gtr:id><gtr:title>New zebrafish models of neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Current neurology and neuroscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f73573fc1422aa1c468be7948a598794"><gtr:id>f73573fc1422aa1c468be7948a598794</gtr:id><gtr:otherNames>Mart?n-Jim?nez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1528-4042</gtr:issn><gtr:outcomeId>58c7d29361a6d4.19879191</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>314255CF-7207-429F-A492-099AD53D8104</gtr:id><gtr:title>TSPO: kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94366f16d8e04e920c02db3b18cf29e7"><gtr:id>94366f16d8e04e920c02db3b18cf29e7</gtr:id><gtr:otherNames>Gatliff J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>56ded254d38569.09261921</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6274AA4-A06D-49E3-A872-3CC7E1A9D79D</gtr:id><gtr:title>TSPO: functions and applications of a mitochondrial stress response pathway.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7c63f89cbea82fb1d59d999de7a678"><gtr:id>9f7c63f89cbea82fb1d59d999de7a678</gtr:id><gtr:otherNames>Campanella M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>58c7d2933a28e1.13660933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1379C48-10AD-4176-B28D-F0C63DFBAA42</gtr:id><gtr:title>TSPO the unrested: challenged opinions of a resourceful mitochondrial protein.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7c63f89cbea82fb1d59d999de7a678"><gtr:id>9f7c63f89cbea82fb1d59d999de7a678</gtr:id><gtr:otherNames>Campanella M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>56ded3b7eea2a0.58445427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AC1680B-5163-4D7E-9198-37A3941E1668</gtr:id><gtr:title>Peptide targeting of mitochondria elicits testosterone formation.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7c63f89cbea82fb1d59d999de7a678"><gtr:id>9f7c63f89cbea82fb1d59d999de7a678</gtr:id><gtr:otherNames>Campanella M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>5457a796250ff5.71262603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6E30AC0-3189-4DEA-91A2-1DDB34825E07</gtr:id><gtr:title>IF1 limits the apoptotic-signalling cascade by preventing mitochondrial remodelling.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/432a93a0abc1c455d7acbe3bdeeae1de"><gtr:id>432a93a0abc1c455d7acbe3bdeeae1de</gtr:id><gtr:otherNames>Faccenda D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>doi_55f94d94d6ce9987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97E31D0E-68FD-468F-AABE-46D21E2AB8E2</gtr:id><gtr:title>TSPO is a REDOX regulator of cell mitophagy.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94366f16d8e04e920c02db3b18cf29e7"><gtr:id>94366f16d8e04e920c02db3b18cf29e7</gtr:id><gtr:otherNames>Gatliff J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>56ded3b7ce4716.14061852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47286B9C-7E7F-4DB2-9532-6490B1CD76B9</gtr:id><gtr:title>AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12c01cd994772e06b58e76a33ac22d5e"><gtr:id>12c01cd994772e06b58e76a33ac22d5e</gtr:id><gtr:otherNames>Strappazzon F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>56ded3b81c8456.30705707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EB425FD-75BC-47C9-A6C6-4D59759B82B6</gtr:id><gtr:title>Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e2b35510da18c4d24ede0199ba63a6c"><gtr:id>4e2b35510da18c4d24ede0199ba63a6c</gtr:id><gtr:otherNames>Liao C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c7d29271a257.14067985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EC4A5FC-F86B-455A-8161-BF64F61833CA</gtr:id><gtr:title>Cell metabolism sets the differences between subpopulations of satellite cells (SCs).</gtr:title><gtr:parentPublicationTitle>BMC cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b5bcb0fe3738e2700ecdbdefbf2634a"><gtr:id>3b5bcb0fe3738e2700ecdbdefbf2634a</gtr:id><gtr:otherNames>Repele A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2121</gtr:issn><gtr:outcomeId>doi_55f94d94d6eb5f0a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6ADB6C9A-C14F-4F75-9617-3BA7ED582231</gtr:id><gtr:title>Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f446e86d6836d8e6a5da49dfe563b87"><gtr:id>8f446e86d6836d8e6a5da49dfe563b87</gtr:id><gtr:otherNames>Galluzzi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>5457a795eef3c3.42285556</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>182405B1-469A-44F3-9025-70DF396A9548</gtr:id><gtr:title>Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3cf9b7c8384740d5adefa12eb7a3dfc2"><gtr:id>3cf9b7c8384740d5adefa12eb7a3dfc2</gtr:id><gtr:otherNames>Rossin F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>545bafc1e6e418.45304106</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA2F4C16-C241-41F7-8D33-EA2BA081E06A</gtr:id><gtr:title>The 18 kDa translocator protein (TSPO): a new perspective in mitochondrial biology.</gtr:title><gtr:parentPublicationTitle>Current molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94366f16d8e04e920c02db3b18cf29e7"><gtr:id>94366f16d8e04e920c02db3b18cf29e7</gtr:id><gtr:otherNames>Gatliff J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1566-5240</gtr:issn><gtr:outcomeId>5457a718371551.72736869</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEFF8232-59A1-4943-B33A-AFA4F7D50E19</gtr:id><gtr:title>Editorial: The physiology and pharmacology of the mitochondrial 18 kDa translocator protein (TSPO): an emerging molecular target for diagnosis and therapy.</gtr:title><gtr:parentPublicationTitle>Current molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7c63f89cbea82fb1d59d999de7a678"><gtr:id>9f7c63f89cbea82fb1d59d999de7a678</gtr:id><gtr:otherNames>Campanella M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1566-5240</gtr:issn><gtr:outcomeId>5460ba43094285.61803138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>592BE9B1-97E7-49FD-9C6D-ED0E9A6BDC1A</gtr:id><gtr:title>PK11195 inhibits mitophagy targeting the F1Fo-ATPsynthase in Bcl-2 knock-down cells.</gtr:title><gtr:parentPublicationTitle>Current molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d65928d050b0e7e67eeed6d0f03428f8"><gtr:id>d65928d050b0e7e67eeed6d0f03428f8</gtr:id><gtr:otherNames>Seneviratne MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1566-5240</gtr:issn><gtr:outcomeId>5457a8b4de83f0.56145099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>971FC36E-1DB3-4F12-83A5-4F9611A311AD</gtr:id><gtr:title>Type 2 Transglutaminase, mitochondria and Huntington's disease: menage a trois.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea1f5e9bf29226e3c2fbef689e1bb728"><gtr:id>ea1f5e9bf29226e3c2fbef689e1bb728</gtr:id><gtr:otherNames>Altuntas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>5457aa5e81d0e4.35123667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADB10526-01CB-4959-8A98-1B13764F470C</gtr:id><gtr:title>HtrA2 deficiency causes mitochondrial uncoupling through the F1F0-ATP synthase and consequent ATP depletion.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1a768ac0348b89871dc88cb7217499f"><gtr:id>d1a768ac0348b89871dc88cb7217499f</gtr:id><gtr:otherNames>Plun-Favreau H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>56e177cc89d650.95245884</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/I013695/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>